Navigation Links
Investor Group Commends Clint Severson for Joining Trinity Biotech's Board of Directors
Date:11/20/2008

KANSAS CITY, Mo., Nov. 20 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products whose shares are traded in the form of American Depository Receipts on NASDAQ, is encouraged that Clint Severson has joined the company's board of directors.

Commenting on the news, Tom Reidy stated, "We are delighted that Clint has agreed to serve as an independent director, bringing the total of independent directors to two. While Clint's appointment is a step in the right direction, we continue to believe that the election of an independent director controlled board is essential to an increase in company share value. We look forward to Clint remaining as part of our new board immediately following our pending action to remove and replace the current board."

In October, the investor group directed that Trinity Biotech shareholders be given the opportunity to vote on a slate of replacement directors, including Mr. Severson. The remaining proposed slate consists of the following individuals:

     1. Dr. Jack C. Chow, M.D., M.B.A. -- Partner, CRV Capital, LLC and
        adjunct professor at Carnegie Mellon University's Heinz School of
        Public Policy and Management;
     2. Mr. Mike Gausling -- Managing Partner, Originate Ventures;
     3. Dr. John H. Halsey, Ph.D. -- Chief Executive Officer, Director,
        Founder, ProGene Biomedical, Inc. (dba IBT Laboratories);
     4. Mr. Steven A. Mock, CPA -- Partner, BKD, LLP; and
     5. Mr. Thomas Reidy.

Further commenting on the appointment of Mr. Severson, Tom Reidy stated that 'based on several conversations with Mr. Severson, I believe we are totally aligned on the aspects of effective corporate governance, transparency of board and company actions, and performance-based remuneration programs. Clint's emphasis on management accountability and the need for sharp focus and effective strategic planning are essential in today's marketplace. We just need more people like Clint on the board '.


'/>"/>
SOURCE KC Investor Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. SXC Health Solutions to host analyst and institutional investor event
2. Unilever Investor Relations Seminar
3. ProAssurance to Present at Oppenheimer Investor Conference
4. Surgical Care Affiliates Announces Investor Conference Call to Discuss Third Quarter 2008 Results
5. Alexion to Present at Investor Conferences
6. Jazz Pharmaceuticals to Present at Investor Conferences
7. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
8. BD to Present at Investor Healthcare Conferences
9. VirtualScopics to Present at Two Upcoming Investor Conferences
10. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
11. Robbins & Myers to Present at Sidoti & Company Investor Conference on November 10, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: